Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1246.2%
Neutral1453.8%
Bearish00.0%
FN2 Earnings Intelligence
Raymond James Financial, Inc. analyst ratings
Raymond James Financial, Inc. (RJF) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$175.98Previous close
$123Low
$158.81Average
$205High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Aug 1, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Jul 30, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 23, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 23, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Dec 10, 2025 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 23, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Sep 22, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 11, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 8, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2023 |
| Seaport Global | Buy | Neutral | Upgrade | Jan 28, 2022 |
| Compass Point | Neutral | Buy | Downgrade | May 1, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Oct 26, 2018 |
| Buckingham | Buy | Buy | Maintain | Oct 26, 2018 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Feb 27, 2018 |
| Nomura | Buy | Buy | Maintain | Jul 13, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Susquehanna | Positive | Positive | Maintain | Jul 15, 2015 |
| S&P Capital IQ | Strong Buy | Buy | Upgrade | Jul 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $175.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $184 | $172.75 | +4.6% | Jul 27, 2026 |
| Raymond James | Michael Cho | $179 | $164.91 | +1.7% | Jul 23, 2026 |
| Raymond James | Brennan Hawken | $175 | $165.16 | -0.6% | Jul 23, 2026 |
| Raymond James | Devin Ryan | $205 | $168.01 | +16.5% | Jul 23, 2026 |
| Raymond James | Analyst unavailable | $174 | $169.45 | -1.1% | Jul 10, 2026 |
| Raymond James | Analyst unavailable | $192 | $169.9 | +9.1% | Jul 9, 2026 |
| Raymond James | Analyst unavailable | $200 | $165.35 | +13.6% | Jul 9, 2026 |
| UBS | Michael Brown | $175 | $166.58 | -0.6% | Jul 8, 2026 |
| Raymond James | Analyst unavailable | $155 | $143.22 | -11.9% | May 28, 2026 |
| UBS | Analyst unavailable | $166 | $156.16 | -5.7% | Apr 23, 2026 |
| Raymond James | Analyst unavailable | $172 | $155.91 | -2.3% | Apr 23, 2026 |
| Raymond James | Michael Cyprys | $171 | $145.35 | -2.8% | Apr 10, 2026 |
| Raymond James | Analyst unavailable | $156 | $148.14 | -11.4% | Apr 9, 2026 |
| Raymond James | Analyst unavailable | $165 | $147.82 | -6.2% | Apr 8, 2026 |
| UBS | Analyst unavailable | $158 | $147.82 | -10.2% | Apr 8, 2026 |
| Raymond James | Analyst unavailable | $198 | $165.86 | +12.5% | Feb 1, 2026 |
| Raymond James | Analyst unavailable | $191 | $169.02 | +8.5% | Jan 28, 2026 |
| Raymond James | Michael Cyprys | $187 | $163.01 | +6.3% | Dec 22, 2025 |
| UBS | Michael Brown | $176 | $166.94 | +0.0% | Dec 11, 2025 |
| Raymond James | Analyst unavailable | $196 | $165.79 | +11.4% | Dec 10, 2025 |
| Raymond James | Analyst unavailable | $194 | $164.98 | +10.2% | Oct 23, 2025 |
| Raymond James | Brennan Hawken | $182 | $166.04 | +3.4% | Oct 23, 2025 |
| Raymond James | Analyst unavailable | $181 | $166.04 | +2.9% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $190 | $162.06 | +8.0% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $185 | $165.15 | +5.1% | Oct 9, 2025 |
| Raymond James | Analyst unavailable | $178 | $167.64 | +1.1% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $173 | $165.9 | -1.7% | Oct 2, 2025 |
| Raymond James | Analyst unavailable | $184 | $168.6 | +4.6% | Oct 1, 2025 |
| Raymond James | Devin Ryan | $180 | $159.31 | +2.3% | Jul 14, 2025 |
| Raymond James | Craig Siegenthaler | $159 | $137.26 | -9.6% | Apr 24, 2025 |
| Raymond James | Analyst unavailable | $161 | $144.19 | -8.5% | Mar 4, 2025 |
| Raymond James | Christopher Allen | $170 | $154.21 | -3.4% | Jan 10, 2025 |
| Raymond James | William Kirk | $150 | $149.05 | -14.8% | Oct 30, 2024 |
| Raymond James | Michael Cyprys | $132 | $136.51 | -25.0% | Oct 17, 2024 |
| Raymond James | Devin Ryan | $146 | $124.9 | -17.0% | Oct 9, 2024 |
| Wells Fargo | Christopher Harris | $138 | $115.95 | -21.6% | Sep 11, 2024 |
| Raymond James | Daniel Fannon | $123 | $119.51 | -30.1% | Jul 8, 2024 |
| Raymond James | William Kirk | $130 | $125.36 | -26.1% | May 24, 2024 |
| Raymond James | Bill Katz | $126 | $123.39 | -28.4% | May 24, 2024 |
| Seaport Global | Jim Mitchell | $139 | $129.61 | -21.0% | Apr 4, 2024 |
| Raymond James | Mark McLaughlin | $145 | $128.43 | -17.6% | Apr 2, 2024 |
| Raymond James | Mark McLaughlin | $122 | $106.83 | -30.7% | Sep 11, 2023 |
| UBS | Analyst unavailable | $125 | $110.71 | -29.0% | Jan 9, 2023 |
| Raymond James | Analyst unavailable | $130.07 | $67.71 | -26.1% | Apr 29, 2022 |
| Morgan Stanley | Manan Gosalia | $128 | $98.45 | -27.3% | Mar 14, 2022 |
Track every rating change on RJF the moment it posts. Free to start.
Start free